GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
6.5k
c/tirzepatide·posted 1 year ago by u/elin_ferrari

6 months in and Mounjaro is still the thing I get wrong

Results Clean Column ×7 Cold Box ×3 Sourced ×3

I have had 10 orders now and I keep a table, so here is the honest summary rather than a vibe.

Material has been consistent. Communication has not. Shipping has varied by about 8 days on nominally the same lane, which matters more in summer than in February.

The independent number came back 99.0% against a claimed 98.0%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.

Batch number is in the comments. Ask if you want the method.

7,543 up / 1,001 down88% upvoted12 commentsid 17w8j119 Aug 2024

12 comments

7 in this archive, depth 3

best — the order this archive was captured in

u/bastian_ekstrom1.1k points·1 year ago·edited
controversial sort brought me here and it was worth it
replysharereportpermalink
u/kian_ekstrom351 points·1 year ago

SURMOUNT data is messier than STEP data but the weight loss is there

replysharereportpermalink
u/ingrid_correia98 points·1 year ago

Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.

replysharereportpermalink
u/incretin_ivyMOD812 points·1 year ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/curious_panel_only-23 points·1 year ago

Tracking number removed.

Adding to this: Mounjaro is doing more work than the comment implies.

replysharereportpermalink
u/aurel_lindqvist499 points·1 year ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/blunt_coldbox29373 points·1 year ago

the dual agonism hits different and that is why people describe it differently

replysharereportpermalink
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →